In addition, we assessed the expression of molecules such as ANKRD22, GINS3, POLE2, PLEK2, FERMT1 and METTL14 in subcutaneous tumours (Figure S11A) and lung metastatic tissues (Figure S11B). This evidence concerns the gene POLE2 and neoplasm.